Silence Therapeutics
OrganizationHeard on podcasts recently
Silence Therapeutics plc is a clinical-stage biotechnology company developing precision-engineered medicines based on RNA interference (RNAi), particularly short interfering RNA (siRNA) therapeutics. Its pipeline targets diseases with significant unmet medical need, including hematologic and cardiometabolic conditions, using its proprietary delivery and gene-silencing technologies.
Rank this week
Share of the conversation
Reach this week
Tone this week
Not enough signal yet (fewer than 3 episodes scored).
Share of the conversation
Mentions of Silence Therapeutics per 1,000 mentions of anything, 7-day rolling, all podcasts.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Oct 19 | 0.01‰ | 1 |
| Oct 20 | 0.03‰ | 2 |
| Oct 23 | 0.04‰ | 2 |
| Oct 26 | 0.04‰ | 1 |
Who is saying what about Silence Therapeutics
Verified quotes from the last 90 days: who made the most claims, and which way they leaned.
- Matthew Cloutier1 claim on 1 show
“the deal was for about $1.3 billion”
Breaking Biotech · Oct 26 ↗ - Ali Mortazavi1 claim on 1 show
“someone in silence, i don't know who, decided to switch to PV. And honestly, that's probably one of the best, best biotech corporate decisions ever made.”
Biotech Hangout · Oct 23 ↗
Discussed alongside
Names that come up in the same conversations as Silence Therapeutics.
Embed this
Paste this on your site to show Silence Therapeutics's current trend:
<iframe src="https://podlume.ai/embed/e/silence-therapeutics" width="360" height="220" style="border:0" loading="lazy" title="Silence Therapeutics on PodLume Trends"></iframe>